Brentuximab vedotin-containing escalated BEACOPP variants for newly diagnosed advanced-stage classical Hodgkin lymphoma: follow-up analysis of a randomized phase II study from the German Hodgkin Study Group
Autor/innen
- C. Damaschin
- H. Goergen
- S. Kreissl
- A. Plütschow
- F. Breywisch
- S. Mathas
- J. Meissner
- M. Sökler
- M.S. Topp
- V. Vucinic
- A. Zimmermann
- B. von Tresckow
- M. Fuchs
- A. Engert
- P. Borchmann
- D.A. Eichenauer
Journal
- Leukemia
Quellenangabe
- Leukemia 36 (2): 580-582